ArticleJournal of medical economicsPublished
Cost-per-responder analysis of TAR-200 versus other Food and Drug Administration-approved novel and generic treatments among patients with Bacillus Calmette-Guérin-unresponsive, high-risk, non-muscle-invasive bladder cancer with carcinoma in situ in the United States
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of medical economics
- Published
- Topic
- Public health
- Subject terms
- Humans; Carcinoma in Situ; Antineoplastic Agents; BCG Vaccine; Administration, Intravesical; United States Food and Drug Administration; Aged; Medicare; United States; Female; Male; Urinary Bladder Neoplasms
- PubMed ID
- 42012856
- Added to directory
- Source checked